Where to buy and price of Vigabatrin
Vigabatrin is an oral powder mainly used to treat refractory epilepsy, especially infantile spasms (West syndrome). Its main mechanism is to inhibit γ-aminobutyric acid (GABA) aminotransferase, increase the concentration of GABA in the brain, reduce nerve excitation, and thereby effectively control epileptic seizures. This drug is particularly suitable for patients who do not respond well to traditional anti-epileptic drugs, especially infants and other refractory epilepsy types.
Vigabatrin dosage is usually adjusted based on the patient's weight and condition. Because it is in powder form, patients have more flexibility to adjust the dosage as needed. During treatment, doctors will regularly monitor the patient's reactions and side effects to ensure the effectiveness and safety of the drug.

Regarding the purchasing channels, Vigabatrin is currently on the market in China and has been included in medical insurance. Specific medical insurance reimbursement policies may vary by region, and patients can consult their local hospital pharmacy for detailed information. According to the current market price, 500mg*30bags of Vigabatrin are sold for about more than one thousand yuan. The specific price may vary depending on regions and pharmacies.
In addition, patients can also choose to purchase original drugs from Hong Kong, China. The drug is also available in 500mg*100 bags. The price is about more than one thousand yuan, and the price/performance ratio is relatively high. At the same time, some foreign generic drugs are cheaper. The price of 500mg drugs of the same specifications is around a few hundred yuan, and the ingredients of the drugs are basically the same as the original drugs.
In conclusion, Vigabatrin, as an effective anti-epileptic drug, provides an important treatment option for patients with refractory epilepsy. When purchasing, patients should pay attention to the price and medical insurance reimbursement policy, and follow the doctor's instructions during use to ensure safety and efficacy.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)